S2N Health
Boston, US · Founded 2023 · Delaware corporation · 34 employees on LinkedIn · 4 known investors
S2N Health provides commercial intelligence, analytics, and go-to-market strategy services for medtech, diagnostics, digital health, and drug delivery companies, from startups to global enterprises. Its RepSignal platform is an AI-powered SaaS tool that consolidates healthcare data into commercial insights and integrates with CRM systems such as Salesforce and HubSpot.
Also known as S2N · S2N Health, Inc.
Founders & leadership
S2N Health was founded in 2023 by Amy Siegel and Tim Kofol.
Board
Investors · 4
Reported raises · per SEC filings
Form D private placements$7.5M disclosed across 3 of 5 rounds · 2023–2026
▶$3MraisedJun 2026 · 25 investors · OtherRule 506(b)
- Martha ShadanDirector
- Roome HughDirector
- Timothy KofolExecutive Officer, Director
- Andrew SchwabDirector
- Amy SiegelExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$4.3MraisedJun 2025 · 34 investors · OtherRule 506(b)
- Martha ShadanDirector
- Timothy KofolExecutive Officer, Director
- Amy SiegelExecutive Officer, Director
- Roome HughDirector
- Andrew SchwabDirector
- Offering amount
- $6.1M
- Amount sold
- $4.3M
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$150KraisedJun 2023 · 3 investors · Other Health CareRule 506(b)
- Timothy KofolExecutive Officer, Director
- Amy SiegelExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $150K
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Company profile
researched Aug 2026S2N Health, Inc. is a Boston, Massachusetts-based company that delivers commercial intelligence for medical technology companies, combining healthcare data, domain expertise in medtech, diagnostics, digital health and drug delivery, and AI-driven analytics. Its stated purpose is to translate large volumes of healthcare data into insights that commercial teams can act on when launching products, entering new markets or expanding market share.
The company's core product is RepSignal, an AI-powered SaaS customer and market intelligence platform launched in 2021. RepSignal consolidates multi-source healthcare data and applies analytics and AI algorithms to produce customer targeting, engagement and resource-planning insights. It is delivered as a stand-alone web platform, via mobile app, or integrated natively into Salesforce CRM; the company also cites integration with HubSpot and other CRM and analytics platforms, and lists RepSignal on the Salesforce AppExchange. Alongside software, S2N Health provides data-enabled services and go-to-market and growth strategy work spanning the commercial lifecycle from pre-launch through M&A.
Leadership includes co-founder and CEO Amy Siegel and co-founder and CTO Tim Kofol, with additional executives covering sales, operations and strategic growth. The board includes Martha Shadan, Andrew Schwab (Excelerate Health Ventures), Ren Roome (Boston Millennia Partners), Sushma Rajagopalan (Rittenhouse Ventures), Steve Schaefer, and Dan Coppens (observer, Robin Hood Ventures), supported by an advisory group of former Medtronic, Boston Scientific and other medtech executives.
Founding story
S2N Health was founded by a team combining medtech industry, healthcare analytics and software development backgrounds. Co-founder and CEO Amy Siegel brought medtech industry experience that shaped RepSignal's development, while co-founder and CTO Tim Kofol led the architecture and algorithms behind the platform's data consolidation and AI-powered analytics. According to the company, years of advising medtech companies showed that many held substantial data but struggled to deploy it within commercial teams, which motivated the product.
Business model
S2N Health sells a SaaS commercial intelligence platform, RepSignal, to healthcare technology companies, either as a stand-alone web and mobile product or integrated into the customer's CRM, and complements it with data-enabled services and go-to-market and growth strategy engagements.
Revenue derives from subscription access to the RepSignal SaaS platform, sold stand-alone or via CRM integration, together with data-enabled services and commercial strategy engagements.
Traction
S2N Health reports having collaborated with over 180 companies and states that its seed round followed market traction for RepSignal among large and emerging medtech companies. A published customer case study describes Tactile Medical using S2N Health to drive sales efficiency. Third-party directory data lists the company at 11-50 employees.
Latest developments
In August 2025 S2N Health announced that Rittenhouse Ventures had completed an investment in the company, joining existing investors Excelerate Health Ventures, Boston Millennia Partners and Robin Hood Ventures, with Rittenhouse partner Sushma Rajagopalan joining the board. The company said it would use the investment to expand its reach in MedTech and advance its AI roadmap, and noted a recently expanded Salesforce partnership including development on Agentforce.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
S2N Health positions itself in the MedTech commercial intelligence segment, describing its offering as an end-to-end customer intelligence platform for medtech, and reports collaboration with more than 180 companies and market traction for RepSignal across large and emerging medtech firms.
The company attributes its differentiation to the combination of expert curation and deep medtech domain expertise with multi-sourced healthcare data and AI-powered analytics, plus native Salesforce CRM integration and delivery across web, mobile and CRM environments.
Technology
The platform applies AI algorithms and advanced analytics to a proprietary, multi-sourced healthcare data layer, consolidating large volumes of data into customer- and market-level insights. It is accessible by web, mobile app, or native integration with Salesforce CRM, and can also be connected to HubSpot and other CRM and analytics systems. The company has expanded its Salesforce partnership to include development on Agentforce, Salesforce's AI platform, to bring agentic capabilities to medtech sales workflows.
Go-to-market
The company sells directly to medtech organizations and distributes RepSignal through the Salesforce AppExchange, using CRM integration as a primary channel. It publishes case studies, articles and webinars on topics such as national and strategic accounts, account-based marketing and market entry strategy, and has expanded its partnership with Salesforce.
Medtech, diagnostics, digital health and drug delivery companies, ranging from startups to large global enterprises, with the platform aimed at sales, marketing, business development, product management and market strategy teams.
Geography
Headquartered in Boston, Massachusetts, United States, serving medtech companies including leading global organizations.
History
The company states it was established in 2011 and has worked with more than 180 companies on analytics and insight projects. In 2021 it launched RepSignal, its AI-powered commercial intelligence platform. In May 2024 it announced seed funding led by Excelerate Health Ventures and added Martha Shadan to its board. In August 2025 it announced an investment from Rittenhouse Ventures, whose partner Sushma Rajagopalan joined the board, and disclosed an expanded Salesforce partnership covering development on Agentforce.
Compiled by commissioned research from 7 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 2
by search overlap
Companies competing with S2N Health for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 6
launches, deals, and filingsPhiladelphia-based Rittenhouse Ventures completed an investment in S2N Health, joining existing investors Excelerate Health Ventures, Boston Millennia Partners and Robin Hood Ventures.
Rittenhouse Ventures Partner Sushma Rajagopalan joined the S2N Health Board of Directors in connection with the firm's investment.
S2N Health said it had recently expanded its partnership with Salesforce to include development on Agentforce, Salesforce's AI platform, to bring agentic solutions to MedTech sales.
S2N Health announced a seed round to fuel growth of its RepSignal medtech customer intelligence SaaS platform and develop an AI-powered product roadmap, led by Excelerate Health Ventures with participation from Boston Millennia Partners and Robin Hood Ventures.
S2N Health expanded its Board of Directors with medtech executive Martha Shadan, joining Andrew Schwab of Excelerate Health Ventures and Ren Roome of Boston Millennia Partners.
S2N Health launched RepSignal, an AI-powered SaaS commercial intelligence platform for healthcare technology companies, usable stand-alone or integrated with Salesforce, HubSpot and other CRM and analytics platforms.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
Legal entities · 1
corporate structureIn the news
▸Research sources · 7
primary sources listed
- S2N Healths2nhealth.com · web
7 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does S2N Health do?
- S2N Health provides AI-powered commercial intelligence software and data-enabled services for medtech companies.
- Who founded S2N Health?
- S2N Health was founded by Amy Siegel, Tim Kofol in 2023.
- Who are S2N Health's investors?
- S2N Health's investors include Excelerate Health Ventures, Rittenhouse Ventures, Robin Hood Ventures, Boston Millennia Partners.
- How much funding has S2N Health raised?
- S2N Health has disclosed $7.5M raised across 3 of its 5 known rounds.
- Where is S2N Health headquartered?
- S2N Health is headquartered in Boston, US.